Efficacy of botulinum toxin in severe Tourette syndrome with dystonic tics involving the neck

Parkinsonism and Related Disorders

Volumn 14, Issue 5, 2008, Pages 443-445

  Aguirregomozcorta, Maria ^a   Pagonabarraga, Javier ^b,c   Diaz Manera, Jordi ^b,c   Pascual Sedano, Berta ^b,c   Gironell, Alexandre ^b,c   Kulisevsky, Jaime ^b,c  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Botulinum toxin; Dystonic tics; Myelopathy; Tourette syndrome

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; HALOPERIDOL; PIMOZIDE; RISPERIDONE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CERVICAL MYELOPATHY; CLINICAL EXAMINATION; CLINICAL FEATURE; DYSTONIA; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPERSALIVATION; INTERVERTEBRAL DISKECTOMY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOTHERAPY; PRIORITY JOURNAL; QUADRIPLEGIA; SIDE EFFECT; SOMNOLENCE; TIC; TREATMENT OUTCOME; VERTEBRAL CANAL STENOSIS; WEIGHT GAIN;

ADULT; ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; TIC DISORDERS; TOURETTE SYNDROME;

EID: 46849111622     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2007.10.007     Document Type: Article

References (11)

1. Jankovic J. Tourette's syndrome. N Engl J Med 345 (2001) 1184-1192
2. Jankovic J. Phenomenology and classification of tics. Neurol Clin 15 (1997) 267-275
3. Robertson M.M. Tourette syndrome, associated conditions and the complexities of treatment. Brain 123 (2000) 425-462
4. Shapiro E., Shapiro A.K., Fulop G., Hubbard M., Mandeli J., Nordlie J., et al. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 46 (1989) 722-730
5. Krauss J.K., and Jankovic J. Severe motor tics causing cervical myelopathy in Tourette's syndrome. Mov Disord 11 (1996) 563-566
6. Dobbs M., and Berger J.R. Cervical myelopathy secondary to violent tics of Tourette's syndrome. Neurology 60 (2003) 1862-1863
7. Adler C.H., Zimmerman R.S., Lyons M.K., Simeone F., and Brin M.F. Perioperative use of botulinum toxin for movement disorder-induced cervical spine disease. Mov Disord 11 (1996) 79-81
8. Jankovic J. Botulinum toxin in the treatment of dystonic tics. Mov Disord 9 (1994) 347-349
9. Kwak C.H., Hanna P.A., and Jankovic J. Botulinum toxin in the treatment of tics. Arch Neurol 57 (2000) 1190-1193
10. Erenberg G., Cruse R.P., and Rothner A.D. The natural history of Tourette syndrome: a follow-up study. Ann Neurol 22 (1987) 383-385
11. Pappert E.J., Goetz C.G., Louis E.D., Blasucci L., and Leurgans S. Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome. Neurology 61 (2003) 936-940